TeaTaze, LLC

CLOSEOUT LETTER TeaTaze, LLC MARCS-CMS 613942 — June 14, 2024 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UPS Product: Dietary Supplements Recipient: Recipient Name Nicholas P Gerstner TeaTaze, LLC 1203 N Fieldcrest St Wichita , KS 67212 United States Issuing Office: Office of Human and Animal Food- West Division II United States Secondary Issuing Offices United States Dear Mr. Gerstner: The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter (CMS Case #: 613942) on July 23, 2021. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ LaTonya M. Mitchell, Ph.D. Program Division Director, Office of Human and Animal Food-West Div. 2 Content current as of: 07/01/2024 Regulated Product(s) Dietary Supplements